Publicaciones (46) Publicaciones de LORENA BENAVENTE FERNANDEZ

2024

  1. Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study

    Neurologia, Vol. 39, Núm. 3, pp. 226-234

2022

  1. First-line Double Stentriever Thrombectomy for M1/TICA Occlusions: Initial Experiences

    Clinical Neuroradiology, Vol. 32, Núm. 4, pp. 971-977

  2. Frailty in people over 80 years after an ischemic stroke treated with mechanical thrombectomy

    Revista Cientifica de la Sociedad Espanola de Enfermeria Neurologica, Vol. 56, pp. 29-36

  3. Selection of patients for percutaneous closure in nonlacunar cryptogenic stroke associated with patent foramen ovale. Data from the NORDICTUS cooperative registry

    Neurologia

  4. Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy

    Cerebrovascular Diseases Extra, Vol. 12, Núm. 3, pp. 103-108

2021

  1. Impact of Mediterranean Diet prior to Stroke on the Prognosis of Patients Undergoing Endovascular Treatment

    Cerebrovascular Diseases, Vol. 50, Núm. 3, pp. 303-309

  2. Initial Experience Performing Mechanical Thrombectomy With the CatchView Mini Device for Distal M2 Segment Middle Cerebral Artery Occlusions

    Frontiers in Neurology, Vol. 12

  3. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2020

  1. Dual energy CT in the management of antiplatelet therapy in patients with acute ischemic stroke for carotid obstruction

    Interventional Neuroradiology, Vol. 26, Núm. 2, pp. 222-230

  2. Efficacy and Safety of Endovascular Treatment in Acute Tandem Carotid Occlusions: Analysis of a Single-Center Cohort

    Cerebrovascular Diseases Extra, Vol. 10, Núm. 2, pp. 50-58

  3. Erratum: Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus (Rheumatology (2020) 59 (1752-1764) DOI: 10.1093/rheumatology/keaa016)

    Rheumatology (United Kingdom)

  4. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

  5. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile

    Rheumatology (Oxford, England), Vol. 59, Núm. 2, pp. 407-417

  6. Iron Measured in Nasal Exudate Samples as a New and Useful Biomarker in the Differential Diagnosis of Patients with Acute Stroke

    Cerebrovascular Diseases, Vol. 49, Núm. 6, pp. 625-631

  7. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus

    Rheumatology (Oxford, England), Vol. 59, Núm. 7, pp. 1752-1764

  8. Obtaining information from the brain in a non-invasive way: Determination of iron in nasal exudate to differentiate hemorrhagic and ischemic strokes

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 5, pp. 847-853

2019

  1. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 2, pp. 135-143

  2. Code stroke. Can we improve stroke times? A reply

    Neurologia

  3. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Análisis de los costes directos asociados a la trombectomía mecánica y a la fibrinólisis intravenosa en el hospital universitario central de Asturias

    Revista de Neurologia, Vol. 66, Núm. 1, pp. 7-14